| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK1
Author for correspondence: Geoffrey L. Smith. Present address: Department of Virology, The Wright–Fleming Institute, Faculty of Medicine, Imperial College of Science, Technology and Medicine, St Mary's Campus, Norfolk Place, London W2 1PG, UK. Fax +44 207 594 3973. e-mail glsmith{at}ic.ac.uk
A bioassay that measured the interleukin (IL)-12-induced production of interferon (IFN)-
from mouse splenocytes was used to identify a soluble factor in the supernatants of vaccinia virus (VV)-infected cells that inhibited the production of IFN-. This soluble factor was expressed by 14 out of 16 VV strains including the Western Reserve (WR) strain, but strains Copenhagen and Tashkent and a mutant of strain WR called 6/2 lacked this activity. The gene encoding this activity was identified as C12L by transferring DNA present in VV WR but missing in VV WR 6/2 into VV Copenhagen and testing for expression of the soluble factor. The C12L protein shows amino acid similarity to IL-18 binding proteins that are encoded by poxviruses, mice and humans, and C12L protein produced from VV or baculovirus inhibited the biological activity of mouse IL-18 in vitro. Thus the inhibition of IL-12-induced IFN- production was due to indirect effects of C12L on IL-18, illustrating the synergistic action of these pro-inflammatory cytokines. To study the role of the C12L protein in the virus life-cycle, we constructed a deletion mutant lacking the C12L gene and a revertant virus in which the gene was reinserted into the deletion mutant. In vitro the replication and plaque size of these viruses were indistinguishable. However, infection of BALB/c mice by the intranasal route showed that the deletion mutant was attenuated and induced lower weight loss and signs of illness compared to controls.
This article has been cited by other articles:
|
|
 |
|
  A. S. Fahy, R. H. Clark, E. F. Glyde, and G. L. Smith Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence J. Gen. Virol., October 1, 2008; 89(10): 2377 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Nazarian, M. M. Rahman, S. J. Werden, D. Villeneuve, X. Meng, C. Brunetti, C. Valeriano, C. Wong, R. Singh, J. W. Barrett, et al. Yaba Monkey Tumor Virus Encodes a Functional Inhibitor of Interleukin-18 J. Virol., January 1, 2008; 82(1): 522 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Jacobs, R. A.-J. Chen, C. Gubser, P. Najarro, and G. L. Smith Intradermal immune response after infection with Vaccinia virus. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1157 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Clark, J. C. Kenyon, N. W. Bartlett, D. C. Tscharke, and G. L. Smith Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy J. Gen. Virol., January 1, 2006; 87(1): 29 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jing, T. M. Chong, C. L. McClurkan, J. Huang, B. T. Story, and D. M. Koelle Diversity in the Acute CD8 T Cell Response to Vaccinia Virus in Humans J. Immunol., December 1, 2005; 175(11): 7550 - 7559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Esteban and R. M. L. Buller Ectromelia virus: the causative agent of mousepox J. Gen. Virol., October 1, 2005; 86(10): 2645 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nathaniel, A. L. MacNeill, Y.-X. Wang, P. C. Turner, and R. W. Moyer Cowpox virus CrmA, Myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections J. Gen. Virol., May 1, 2004; 85(5): 1267 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Esteban, A. A. Nuara, and R. M. L. Buller Interleukin-18 and glycosaminoglycan binding by a protein encoded by Variola virus J. Gen. Virol., May 1, 2004; 85(5): 1291 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Reading and G. L. Smith Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity J. Virol., September 15, 2003; 77(18): 9960 - 9968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Gherardi, J. C. Ramirez, and M. Esteban IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system J. Gen. Virol., August 1, 2003; 84(8): 1961 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Reading and G. L. Smith A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection J. Gen. Virol., August 1, 2003; 84(8): 1973 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Johnston and G. McFadden Poxvirus Immunomodulatory Strategies: Current Perspectives J. Virol., June 1, 2003; 77(11): 6093 - 6100. [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Harte, I. R. Haga, G. Maloney, P. Gray, P. C. Reading, N. W. Bartlett, G. L. Smith, A. Bowie, and L. A.J. O'Neill The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense J. Exp. Med., February 3, 2003; 197(3): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
